Recent Articles from Business Wire

Joinable Labs today launched Joinable Security™, the first domain on the Joinable platform, with two products: Joinable Threat Map™, a free utility that lets the security community map, analyze, and share evolving adversary behavior, and Joinable Runbooks™, an enterprise platform that turns an organization's security response documentation into governed knowledge and the agents that act on it.

Please replace the release dated July 29, 2026, with the following corrected version due to multiple revisions.

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines.

4Moving Biotech (4MB), a clinical-stage biotechnology company dedicated to developing first-in-class therapies for inflammatory knee osteoarthritis, today announced the completion of patient enrollment in INFLAM MOTION, its international Phase 2a proof-of-concept study. The trial is evaluating the efficacy and safety of 4P004, an investigational intra-articular GLP-1 receptor agonist designed to address the inflammatory mechanisms underlying both symptoms and disease progression in knee osteoarthritis.

Please replace the release dated July 23, 2026, with the following corrected version due to multiple revisions.

Procore Technologies, Inc. (NYSE: PCOR) (the “Company” or “Procore”), the leading global provider of construction management software, announced today the pricing of $825.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031 (the “notes”) in a private placement (the “offering”) only to persons reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering was upsized from the previously announced offering size of $750.0 million aggregate principal amount of the notes. Procore has also granted the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $125.0 million aggregate principal amount of the notes. The sale of the notes to the initial purchasers is expected to close on August 6, 2026, subject to customary closing conditions.

Hospital for Special Surgery (HSS) once again leads the nation in orthopedic care, earning the No. 1 ranking in orthopedics for a record-setting 17th consecutive year and ranking No. 3 nationally in rheumatology by U.S. News & World Report 2026-2027 Best Hospitals: Specialty Rankings©.

Mitsubishi Electric Corporation (TOKYO: 6503) announced today that its ME Innovation Fund has invested in JIJ Inc., a Japanese startup that uses quantum computers and other technologies to develop middleware for mathematical optimization. The company’s JijZept development platform is highly regarded for helping businesses solve diverse challenges by using mathematical optimization without requiring specialized expertise.

ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) (“ADTRAN Holdings” “ADTRAN” or the “Company”) today announced its unaudited financial results for the second quarter ended June 30, 2026.

Agam Capital (“Agam”), a global leader in technology-enabled insurance-asset and liability management and Sompo Life Re, Ltd (“Life Re”) have entered into a multi-year service agreement to support the operations of a new, Bermuda domiciled life reinsurance platform.

Glenn Flego has spent his career helping financial institutions anticipate change and build innovative capabilities that have shaped how financial advisors serve clients. His work has spanned some of the industry's most influential firms. He joined the original team that developed Charles Schwab's RIA custodial platform, now Schwab Institutional, helped establish Fidelity's RIA brokerage and custody offering, and helped relaunch Raymond James' RIA business. Most recently, he led more than 200 offices for Ameriprise Financial. Today, he advises financial institutions and fintech companies on growth strategy, advisor platforms, and emerging technologies.

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Carrier Global Corporation (“Carrier” or “the Company”) (NYSE: CARR) for violations of the securities laws.

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Innio N.V. (“Innio” or “the Company”) (NASDAQ: INIO) for violations of the securities laws.

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rollins, Inc. (“Rollins” or “the Company”) (NYSE: ROL) for violations of the securities laws.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Pentair plc (“Pentair” or the “Company”) (NYSE: PNR) common stock between April 28, 2026 and July 14, 2026, inclusive (the “Class Period”). Pentair plc investors have until October 2, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Aaron Walters v. , et al1:26-cv-06632, on behalf of persons and entities that purchased or otherwise acquired Pentair plc (“Pentair” or the “Company”) (NASDAQ: PNR) securities between April 28, 2026 and July 14, 2026, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

The Western Union Company (NYSE: WU) announced today that its board of directors declared a quarterly cash dividend of $0.235 per common share, payable September 30, 2026, to stockholders of record at the close of business on September 16, 2026.

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of HCA Healthcare, Inc. (“HCA Healthcare” or the “Company”) (NYSE: HCA) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. (NASDAQ: TMDX).

Riverbend Industries Inc. announced today that it has sold Carlson Acquisition Company (“Carlson”), its Tulsa, Oklahoma-based flange-making subsidiary, to an affiliate of the Zink Family Office, also headquartered in Tulsa. Zink Industrial Group LLC invests in industrial manufacturing and fabrication companies.

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Celcuity Inc. (“Celcuity” or the “Company”) (NASDAQ: CELC) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Wise Group plc (“Wise” or the “Company”) (NASDAQ: WSE) common stock between May 11, 2026 and July 23, 2026, inclusive (“the Class Period”).

Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, today announced a collaboration and co-exclusive licensing agreement with AstraZeneca. Under this agreement, the companies will advance AZD4241, a preclinical investigational therapy for patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer, with Pathos assuming responsibility for the early clinical development of the asset.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) common stock between December 17, 2025 and July 26, 2026, inclusive (“the Class Period”).

Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, today announced a licensing agreement with Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (“Alphamab”), a wholly-owned subsidiary of Alphamab Oncology (Stock Code: 9966.HK), on JSKN016, a first-in-class (FIC) TROP2/HER3 bispecific antibody-drug conjugate (ADC) independently developed by Alphamab.

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of O-I Glass, Inc. (“O-I Glass” or “the Company”) (NYSE: OI) for violations of the securities laws.

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of all persons or entities who held DNOW Inc. (NYSE: DNOW) common stock as of the August 5, 2025 record date and were thus entitled to vote at the September 9, 2025 special meeting. The lawsuit seeks to recover damages for DNOW Inc. investors under the federal securities laws.

Sandisk Corporation (Nasdaq: SNDK) and SK hynix Inc. today announced the release of the HBF™ (High Bandwidth Flash) technical specification through the Open Compute Project (OCP), advancing the workstream to drive HBF standardization for the AI inference era, just six months after the consortium began work in February.

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Bloom Energy Corporation (NYSE: BE) securities between February 27, 2025 and July 8, 2026, both dates inclusive (the “Class Period”), have until September 28, 2026 to seek appointment as lead plaintiff of the Bloom Energy class action lawsuit. Captioned Nevins v. Bloom Energy Corporation, No. 26-cv-07944 (N.D. Cal.), the Bloom Energy class action lawsuit charges Bloom Energy and certain of Bloom Energy’s top executives with violations of the Securities Exchange Act of 1934.

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Avis Budget Group, Inc. (“Avis” or the “Company”) (NasdaqGS: CAR) of a class action securities lawsuit.

Anthem Blue Cross and Blue Shield of Georgia and Northside Radiology Associates (NRA) today announced a new multi-year agreement that ensures Anthem members will continue to have uninterrupted, in-network access to comprehensive diagnostic and interventional radiology services across Georgia.

Laird Superfood, Inc. (NYSE American: LSF) will report financial results for the second quarter ended June 30, 2026 on Thursday, August 13, 2026 after market close. Management will host a webcast at 5:00 p.m. ET on the same day to discuss the results.

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alnylam Pharmaceuticals, Inc. (“Alnylam” or “the Company”) (NASDAQ: ALNY) for violations of the securities laws.

Otter Tail Corporation (Nasdaq: OTTR) today announced financial results for the quarter ended June 30, 2026.

Banner Corporation (NASDAQ: BANR) (“Company”), the parent company of Banner Bank, today announced that its Board of Directors has authorized the repurchase of up to 1.7 million shares of the Company’s common stock, which is approximately 5% of its issued and outstanding common stock.

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors Bowhead Specialty Holdings Inc. (“Bowhead” or “the Company”) (NYSE: BOW) for potential breaches of fiduciary duty on the part of its directors and management.

Triad Business Bank has appointed Brent Burgess to its board of directors.

Watts Water Technologies, Inc. (NYSE: WTS) today, Monday, August 3, 2026, declared that the Corporation will pay a quarterly dividend of Sixty-three cents ($0.63) per share on each outstanding share of the Company’s Class A Common Stock and Class B Common Stock, said dividend to be paid on September 15, 2026, to stockholders of record at the close of business on September 1, 2026.

Global business travel spending is forecast to reach a record $1.71 trillion USD in 2026, with the number of business trips worldwide expected to surpass 1.84 billion. The forecast highlights how rising transportation and travel costs are increasingly driving higher industry prices, ahead of the number of trips.

Better Home & Finance Holding Company (NASDAQ: BETR) (“Better” or the “Company”), the leading AI-native homeownership company, today announced that the Company’s Board of Directors (the “Board”) has appointed Board member, Daniel Lewis, Interim Chief Executive Officer, effective immediately. Mr. Lewis succeeds Founder Vishal Garg, who has mutually agreed with the Board to transition from his role as Chief Executive Officer. Mr. Garg will continue to serve on the Board and work closely with Mr. Lewis to ensure an orderly and effective leadership transition.

Black Stone Minerals, L.P. (NYSE: BSM) ("Black Stone Minerals," "Black Stone," or "the Partnership") today announces its financial and operating results for the second quarter of 2026.

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR), including those who bought Avis common stock to cover a short position, between February 20, 2025 and April 21, 2026, inclusive (the “Class Period”).

Paycom Software, Inc. (“Paycom”) (NYSE: PAYC), a leading provider of comprehensive, cloud-based human capital management software, announced today that its Board of Directors declared a cash dividend in the amount of $0.375 per share of common stock, to be paid on Sept. 8, 2026, to all stockholders of record as of the close of business on Aug. 24, 2026.

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced new data from the Phase 3 VISIONARY trial demonstrating that VOYXACT® (sibeprenlimab-szsi) stabilizes estimated glomerular filtration rate (eGFR) returning kidney function decline to baseline physiologic rate over two years (24 months) in adults with primary IgA nephropathy (IgAN) at risk for disease progression. Results presented during a late-breaking oral presentation at the GlomCon Hawaii 2026 conference showed the study achieved its key secondary endpoint, with an annualized eGFR slope of +0.3 (95% CI, -0.4 to 0.9) mL/min/1.73 m²/year with sibeprenlimab versus -4.2 (95% CI, -4.9 to -3.6) mL/min/1.73 m²/year with placebo, demonstrating a statistically significant treatment effect of +4.5 (95% CI, 3.6 to 5.4; p<0.0001) mL/min/1.73 m²/year at two years (24 months). VOYXACT is the first IgAN treatment to achieve the KDIGO therapeutic goal of effectively halting progressive kidney function decline to physiologic rate (<1 mL/min/1.73 m²/year for most adults)1. The overall safety profile of sibeprenlimab remained consistent through two years (24 months) and was comparable to placebo, with similar rates of overall adverse events (90.7% vs 90.0%), infections and infestations (51.4% vs 51.0%), and injection site reactions (35.1% vs 32.2%). No new safety signals were identified, and rates of serious infections were lower with sibeprenlimab than placebo (1.9% vs 4.0%), alongside lower rates of serious and severe adverse events and treatment discontinuations. A complete analysis of the Phase 3 VISIONARY two-year (24-month) results will be presented at an upcoming scientific congress.

Northern Trust Corporation (Nasdaq: NTRS) today announced the redemption on October 1, 2026 (the “Redemption Date”), of all 5,000 outstanding shares of its Series D Non-Cumulative Perpetual Preferred Stock, $100,000 liquidation preference per share (the “Series D Preferred Stock”), and the corresponding redemption of all 500,000 outstanding depositary shares (CUSIP No. 665859 AQ7) (the “Depositary Shares”), each representing a 1/100th interest in a share of Series D Preferred Stock. The Depositary Shares are not listed on a national securities exchange and will be redeemed at a redemption price of $1,000.00 per Depositary Share. Such redemption price does not include the regular quarterly dividend of $23.00 per Depositary Share that was previously declared and will be paid on the Redemption Date in the ordinary course to holders of record as of 5:00 p.m. Chicago time on September 15, 2026.

N-able, Inc. (NYSE:NABL), a global cybersecurity company delivering business resilience, today announced that it will host a conference call to discuss its financial results for the second quarter of 2026 at 8:30 a.m. ET on August 10, 2026.

Citizens Financial Group, Inc. (NYSE: CFG) announced that its board of directors has declared the following dividends on its preferred stock payable on October 6, 2026, to preferred shareholders of record at the close of business on September 21, 2026:

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ:CAPR) and certain of the company’s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.

Innovative Industrial Properties, Inc. (NYSE: IIPR) ("IIP" or the "Company") announced today results for the second quarter ended June 30, 2026.

The Boards of Trustees/Directors of the PIMCO closed-end funds below (each, a “Fund” and, collectively, the “Funds”) have declared a monthly distribution for each Fund’s common shares as summarized below.

Innovex International, Inc. (NYSE: INVX) (“Innovex,” the “Company” or “we”) today announced financial and operating results for the second quarter of 2026.

The following Eaton Vance closed-end funds (the “Funds”) announced distributions today as detailed below.

JBG SMITH (NYSE: JBGS) (“JBGS” or the “Company”), a leading owner, operator, and developer of mixed-use properties in the Washington, DC market, today announced that it is postponing the release of its second quarter 2026 financial results. The Company’s quarterly investor package, including its earnings release, was originally scheduled to be released after the close of trading on August 4, 2026.

Versant Media Group, Inc. (NASDAQ: VSNT) today announced the completion of its acquisition of Full Swing, a leading sports technology company whose patented hardware and integrated software are used by consumers, coaches, competitive athletes, and commercial venues.

Ryder System, Inc. (NYSE: R) has been named to TIME’s inaugural “America’s Best Companies 2026” list, ranking among the top 10 companies in the Transportation, Logistics, and Aviation category and No. 307 overall among 1,000 U.S. companies evaluated. The honor highlights Ryder’s strong financial performance, high-performing workplace culture, and commitment to sustainability—placing the company ahead of several industry peers in its category.

Atlas Energy Solutions Inc. (NYSE: AESI) (“Atlas” or the “Company”) today reported financial and operating results for the second quarter ended June 30, 2026.

HealthStream, Inc. (the "Company") (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today announced results for the second quarter ended June 30, 2026.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on July 16, 2026, the Company’s Board of Directors approved “inducement” grants to 95 new employees under Rule 5635(c)(4) of the NASDAQ Listing Rules. The grants entitle employees, in aggregate, to receive up to 112,794 restricted stock units. The grants are outside the Company’s stockholder-approved equity incentive plans and vest annually over four years.

TPG Mortgage Investment Trust, Inc. (NYSE: MITT) (the “Company”) announced today that it will release second quarter 2026 financial results prior to market open on Monday, August 10, 2026. The Company will host a conference call to discuss the results on Monday, August 10, 2026, at 8:30 a.m. Eastern Time.

New Jersey Resources Corporation (NYSE: NJR) today reported financial and operating results for its fiscal 2026 third quarter and year-to-date period ended June 30, 2026.

Efficient Markets is excited to support the Colorado State Land Board with its inaugural Request for Proposals (RFP) for geothermal exploration and development of state trust land.

Mettler-Toledo International Inc. (NYSE: MTD) announced today that Natalia Shuman has been appointed to its Board of Directors effective August 3, 2026.

EnCap Flatrock Midstream (“EnCap Flatrock”) today announced the execution of definitive agreements to sell Momentum Midstream (“Momentum,” “M6,” or the “Company”), a leading independent midstream energy company of which EnCap Flatrock is a financial sponsor, to The Williams Companies, Inc. (“Williams”) (NYSE: WMB) for up to $5.5 billion.

Tidewater Inc. (NYSE:TDW) announced today revenue for the three and six months ended June 30, 2026 of $342.3 million and $668.5 million, respectively, compared with $341.4 million and $674.9 million for the three and six months ended June 30, 2025. Tidewater's net income for the three and six months ended June 30, 2026, was $21.7 million ($0.43 per common share) and $27.8 million ($0.56 per common share), respectively, compared with net income of $72.9 million ($1.46 per common share) and $115.6 million ($2.27 per common share), respectively, for the three and six months ended June 30, 2025.

Honeywell Technologies (NASDAQ: HON) today announced the completion of the sale of its Productivity Solutions and Services (PSS) business to Brady Corporation in an all-cash transaction.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Sanara MedTech Inc. (NasdaqCM: SMTI) to MiMedx Group, Inc. (NasdaqCM: MDXG). Under the terms of the proposed transaction, shareholders of Sanara will receive $33.00 in cash and 0.4735 shares of MiMedx common stock for each share of Sanara that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Infraxis, LLC today announced its launch, establishing a utility design and engineering firm focused on helping infrastructure projects move more efficiently from concept to completion.

JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM), a leading global technology solutions provider to high-value segments of the food & beverage industry, today reported financial results for the second quarter of 2026.

Radian Group Inc. (NYSE: RDN) today announced that it has completed the sale of its Real Estate Services business to PLACE, a real estate technology and services platform, and has also entered into a definitive agreement to sell its Title business to PLACE. The pending Title sale is subject to satisfaction of customary closing conditions, including obtaining required regulatory approvals, and is expected to be completed in the fourth quarter.

UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported net income of $20.9 million for its second quarter ended June 30, 2026, 21.4% higher than net income of $17.2 million for the second quarter of 2025. Net sales for the quarter ended June 30, 2026 were $174.0 million, 15.1% higher than 2025 second quarter sales of $151.2 million. Generally accepted accounting principles ("GAAP") and adjusted earnings per diluted common share outstanding ("EPS") for the quarter ended June 30, 2026 were $2.68 and $2.92, respectively. Net sales, net income, and EPS for the second quarter of 2026 reflect record quarterly results for the Company. Net income for the six-month period ended June 30, 2026 was $38.3 million, 11.6% higher than net income of $34.4 million for the same period in 2025. Net sales for the six-month period ended June 30, 2026 were $328.2 million, compared to sales of $299.3 million in the same period of 2025. GAAP and adjusted EPS for the six-month period ended June 30, 2026 were $4.92 and $5.39, respectively.

BRC Inc. (NYSE: BRCC, the "Company" or "Black Rifle"), a Veteran-founded, mission-driven premium beverage company, today announced financial results for the second quarter of fiscal year 2026.

Williams (NYSE: WMB) today announced its unaudited financial results for the three and six months ended June 30, 2026.

Voyager Technologies, Inc. [NYSE: VOYG] (“Voyager” or the “Company”) today announced financial results for the second quarter 2026.

Angel Oak Financial Strategies Income Term Trust (the “Fund”), a closed-end fund traded on the New York Stock Exchange under the symbol FINS, today declared a distribution of $0.115 per share for the month of August 2026. The record date for the distribution is August 17, 2026, and the payable date is August 31, 2026. The Fund will trade ex-distribution on August 17, 2026.

Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter ended June 30, 2026, and provided updated full year 2026 financial guidance, which can be found at the Quarterly Reports section of DHC's website at https://www.dhcreit.com/investors/financial-information/quarterly/default.aspx. The updated full year 2026 financial guidance is consistent with DHC's news release issued on June 1, 2026.